(PDF) PD.1.06 EGFR Uncommon Mutations Frequency in a 1,688

PD.1.06 EGFR Uncommon Mutations Frequency in a 1,688 NSCLC Patients Database in Brazil

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.07.031

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

September 1, 2018

Authors

Publisher

Elsevier BV

Related search

P3.17-01 PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients From Brazil

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-54 a Historical Comparison of Patients With Advanced NSCLC Harboring Uncommon EGFR Mutations Before and After the Approval of Afatinib in Japan

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-31 Updated EGFR Mutation Frequency in 1,689 NSCLC Brazilian Patients – A National-Wide Study

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients With EGFR Mutations: A Real World Assessment

Journal of Thoracic Oncology

Respiratory Medicine

English

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity

Multidisciplinary

English

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

Cancer Research

English

P1.01-44 Outcome of Uncommon EGFR Mutation Positive Newly Diagnosed Advanced NSCLC Patients: A Single-Centre Retrospective Analysis

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

Journal of Thoracic Oncology

Respiratory Medicine

English

First-Line Treatment in NSCLC Harboring EGFR Common Mutations: EGFR TKI in Monotherapy or in Combination With Anti-Vegf?

Expert Review of Anticancer Therapy

English